Cosciens Biopharma Inc

ET8

Company Profile

  • Business description

    Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing pharmaceutical and diagnostic products and active ingredients for the healthcare and cosmetics industries. It operates through two segments: Active Ingredient and Biopharmaceutical. The Active Ingredient segment, which generates maximum revenue, focuses on plant-based ingredients derived from oats and other renewable resources, including oat beta glucan, oat oil, and avenanthramides. The Biopharmaceutical segment focuses on the development and commercialization of therapeutics and diagnostic tests, including its product Macrilen, and advancing a pre-clinical pipeline targeting unmet medical needs, particularly in rare or orphan indications. It operates in Canada, Germany, the United States, and Austria.

  • Contact

    C/o Borden Ladner Gervais Llp
    Suite 3400, 22 Adelaide Street West
    TorontoONM5H 4E3
    CAN

    T: +1 843 900-3223

    E: [email protected]

    https://www.cosciensbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    28

Stocks News & Analysis

stocks

Older cohorts the budget losers, not necessarily the ASX listed insurers

Proposed legislation removes health insurance rebates.
stocks

Turnaround progressing for ASX share

Margins have rebased by shares are undervalued.
stocks

Investors overlooking ASX share’s potential

International expansion is a distraction from valuable local business.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,732.8085.70-0.97%
CAC 407,952.55129.72-1.61%
DAX 4023,950.57505.69-2.07%
Dow JONES (US)49,526.17537.29-1.07%
FTSE 10010,195.37177.56-1.71%
HKSE25,513.06449.67-1.73%
NASDAQ26,225.14410.08-1.54%
Nikkei 22560,843.09566.20-0.92%
NZX 50 Index12,779.82185.19-1.43%
S&P 5007,408.5092.74-1.24%
S&P/ASX 2008,503.9074.00-0.86%
SSE Composite Index4,119.8615.53-0.38%

Market Movers